Can-Fite BioPharma (CANF) Revenue (2015 - 2023)
Can-Fite BioPharma's (CANF) quarterly Revenue came in at $155000.0 in Q4 2023, up 19.23% YoY from $130000.0 in Q4 2022, and down 20.92% on a QoQ basis from $196000.0 in Q3 2023.
Can-Fite BioPharma (CANF) Revenue (2015 - 2023) Analysis & Trends
Can-Fite BioPharma (CANF) has 9 years of Revenue data on file, last reported at $155000.0 in Q4 2023.
- Quarterly Revenue rose 19.23% year-over-year to $155000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $743000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $405000.0, down 39.91% from the prior year.
- Revenue declined to $155000.0 in Q4 2023, from $196000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $1.2 million in Q3 2019 to a low of $130000.0 in Q4 2022.
- A 5-year average of $256700.0 and a median of $204000.0 in 2020 frame the typical range for Revenue.
- Annual changes were most pronounced in 2019 — Revenue jumped 44.07% — and 2020, when it slumped 81.68%.
- Tracing CANF's Revenue over 5 years: stood at $192000.0 in 2019, then slipped by 21.88% to $150000.0 in 2020, then jumped by 36.0% to $204000.0 in 2021, then tumbled by 36.27% to $130000.0 in 2022, then grew by 19.23% to $155000.0 in 2023.
- The last three Revenue figures came in at $155000.0 (Q4 2023), $196000.0 (Q3 2023), and $196000.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Can-Fite BioPharma | 2.82 Mn | -8.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 155,000.00 |
| Sep 30, 2023 | 196,000.00 |
| Jun 30, 2023 | 196,000.00 |
| Mar 31, 2023 | 196,000.00 |
| Dec 31, 2022 | 130,000.00 |
| Sep 30, 2022 | 204,000.00 |
| Jun 30, 2022 | 204,000.00 |
| Mar 31, 2022 | 205,000.00 |
| Dec 31, 2021 | 204,000.00 |
| Sep 30, 2021 | 251,000.00 |
| Jun 30, 2021 | 250,000.00 |
| Mar 31, 2021 | 148,000.00 |
| Dec 31, 2020 | 150,000.00 |
| Sep 30, 2020 | 211,000.00 |
| Jun 30, 2020 | 204,000.00 |
| Mar 31, 2020 | 198,000.00 |
| Dec 31, 2019 | 192,000.00 |
| Sep 30, 2019 | 1.15 Mn |
| Jun 30, 2019 | 389,000.00 |
| Mar 31, 2019 | 299,000.00 |